260 related articles for article (PubMed ID: 18587577)
1. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
2. Improvement of zoledronic-acid-induced jaw osteonecrosis with bortezomib.
Timurağaoğlu A; Ozkaynak C; Tuzuner S; Bostan F; Undar L
Acta Haematol; 2007; 118(4):203-4. PubMed ID: 17992010
[No Abstract] [Full Text] [Related]
3. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
[No Abstract] [Full Text] [Related]
5. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation.
Sakai R; Fujisawa S; Fujimaki K; Kanamori H; Ishigatsubo Y
Bone Marrow Transplant; 2006 Mar; 37(5):537-8. PubMed ID: 16415891
[No Abstract] [Full Text] [Related]
6. Successful bortezomib-based treatment in POEMS syndrome.
Tang X; Shi X; Sun A; Qiu H; Gu B; Zhou H; Xue S; Liu Y; Ruan C; Wu D
Eur J Haematol; 2009 Dec; 83(6):609-10. PubMed ID: 19674063
[No Abstract] [Full Text] [Related]
7. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
8. Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.
Koizumi K; Sawada K; Nishio M; Katagiri E; Fukae J; Fukada Y; Tarumi T; Notoya A; Shimizu T; Abe R; Kobayashi H; Koike T
Bone Marrow Transplant; 1997 Jul; 20(2):171-3. PubMed ID: 9244423
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
10. Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation.
Reimer P; Rüdiger T; Müller J; Rose C; Wilhelm M; Weissinger F
Ann Hematol; 2003 May; 82(5):305-9. PubMed ID: 12707721
[TBL] [Abstract][Full Text] [Related]
11. Expression of constitutively activated NF-κB/mTORC pathway proteins and response to CHOP with bortezomib in a patient with angioimmunoblastic peripheral T-cell lymphoma.
Quesada AE; Rios A; Brown RE; Nguyen ND
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S87-9. PubMed ID: 25486962
[No Abstract] [Full Text] [Related]
12. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib-induced cutaneous lesions in multiple myeloma patients: a case report.
Rodríguez-Martín M; Sáez-Rodríguez M; García-Bustínduy M; Martín-Herrera A; Noda-Cabrera A
Dermatol Online J; 2008 Nov; 14(11):14. PubMed ID: 19094852
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the therapeutic effects of high-dose chemotherapy and autologous stem cell transplantation in T cell lymphoma].
Wang Y; Wu DP; Wu XJ
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):298-9. PubMed ID: 20510084
[No Abstract] [Full Text] [Related]
15. Novel agents in development for peripheral T-cell lymphoma.
O'Connor OA
Semin Hematol; 2010 Apr; 47 Suppl 1():S11-4. PubMed ID: 20359580
[TBL] [Abstract][Full Text] [Related]
16. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
Iino M; Nakajima A; Shindo H
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
[TBL] [Abstract][Full Text] [Related]
17. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
[No Abstract] [Full Text] [Related]
18. Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myeloma.
Buda G; Orciuolo E; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2009; 122(1):39-41. PubMed ID: 19729887
[No Abstract] [Full Text] [Related]
19. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Sato T; Kogawa K; Iyama S; Kobayashi D; Sato Y; Kuribayashi K; Takada K; Hagiwara S; Oku T; Takahashi S; Matsunaga T; Takahashi M; Terui T; Kato J; Niitsu Y
Ann Hematol; 2002 Dec; 81(12):739-43. PubMed ID: 12483373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
